Positive hepatitis B surface antibody
Our workplace recently organized a routine health examination, and I just received the results today—showing a positive hepatitis B surface antibody (HBsAb). I’m unsure what this means. So, what does “positive hepatitis B surface antibody” indicate?
Positive Hepatitis B Surface Antibody
A positive hepatitis B surface antibody (HBsAb) indicates immunity against hepatitis B virus (HBV), meaning you are generally protected from HBV infection. There are two main groups of individuals with this result: First, individuals who have received the hepatitis B vaccine and subsequently developed protective anti-HBs antibodies. In such cases, an anti-HBs level ≥10 IU/L is considered protective against HBV infection. Second, individuals who were previously infected with HBV but successfully cleared the virus due to a robust immune response, leading to the development of anti-HBs. If anti-HBs is positive in conjunction with negative hepatitis B surface antigen (HBsAg) and/or hepatitis B e-antigen (HBeAg), it may suggest seroconversion—a favorable clinical outcome in chronic hepatitis B patients. Such patients require follow-up monitoring every six months to assess viral load fluctuations.

The liver is the organ responsible for synthesizing and secreting bile, producing at least 600–1,000 mL daily. It also synthesizes clotting factors and plays vital roles in immunity and regulation of blood volume. Moreover, the liver possesses remarkable regenerative capacity. Thus, the liver is critically important to overall health.

The most direct and effective method to prevent hepatitis B is vaccination with the hepatitis B vaccine. Following vaccination, the body produces protective antibodies that block HBV entry into hepatocytes. Therefore, in China, newborns receive their first dose of the hepatitis B vaccine immediately after birth. We hope this explanation has been helpful!